Ryman Healthcare Q4 sales rise despite village closures

Grafa
Ryman Healthcare Q4 sales rise despite village closures
Ryman Healthcare Q4 sales rise despite village closures
Brie Carter
Written by Brie Carter
Share

Ryman Healthcare (ASX:RYM) has released its fourth-quarter trading update for the period ended March 31, revealing a robust performance despite structural shifts within its village network.

The aged-care operator reported 331 sales of occupation right agreements for the quarter, marking a 10% increase compared to the same period last year.

The quarterly result contributed to a total of 1,410 ORA sales for the full 2026 financial year.

When excluding the 39 resident relocations necessitated by the progressive closure of the Margaret Stoddart and Woodcote villages, total annual sales reached 1,371, landing squarely within the company’s previously issued market guidance.

CEO Naomi James expressed optimism regarding the group’s trajectory, noting that net sales applications have begun to exceed turnover levels for the first time since contract terms were revised in late 2024.

James highlighted that the new 30% deferred management fee has gained wide market acceptance, driving a steady stream of move-ins from external customers.

While new sales of independent units moderated due to fewer completions, serviced apartment demand remained high, particularly across the Keith Park, Kevin Hickman, and Bert Newton villages.

Ryman maintained a sustained occupancy rate of 96.1% across its mature care centres.

Despite global economic volatility and conflict in the Middle East, the company reported no immediate impact on settled sales.

Frequently asked questions

Connect with us

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.